Immediate Impact
39 standout
Citing Papers
Evolving understanding of autoimmune mechanisms and new therapeutic strategies of autoimmune disorders
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Jiangjiang Li being referenced
Targeting Mitochondrial IDH2 Enhances Antitumor Activity of Cisplatin in Lung Cancer via ROS-Mediated Mechanism
2023
Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jiangjiang Li | 78 | 99 | 8 | 54 | 9 | 183 | |
| Emanuel Bs | 66 | 159 | 15 | 74 | 8 | 255 | |
| Longde Lin | 47 | 60 | 4 | 51 | 9 | 149 | |
| Gladys N. Nangami | 89 | 141 | 10 | 39 | 10 | 225 | |
| Janson W.T. Tse | 78 | 196 | 7 | 62 | 8 | 255 | |
| Aishwarya Sundaresan | 59 | 182 | 12 | 25 | 7 | 229 | |
| Paola Manni | 61 | 116 | 5 | 63 | 9 | 193 | |
| Xuling Sun | 84 | 171 | 11 | 59 | 8 | 269 | |
| Domenico Somma | 42 | 120 | 4 | 35 | 11 | 220 | |
| Suhail A. Ansari | 83 | 141 | 5 | 49 | 11 | 266 | |
| Marc‐Olivier Turgeon | 49 | 170 | 6 | 32 | 8 | 297 |
All Works
Login with ORCID to disown or claim papers
Loading papers...